2Firsts Successfully Hosts 2025 Global NGP Compliance Development Symposium: Spotlighting Emerging Trends and Advancing Industry Compliance
It was such an honor for Dr. Jessica Zdinak, Chief Research Officer, to present the importance of compliance to the U.S. regulatory process and how manufacturers can improve their Module 6 studies to align with FDA’s expectations and needs.
Dr. Jessica Zdinak gave a presentation on the "Challenges and Considerations for Companies Applying for PMTA in 2025," detailing key aspects of the PMTA application process. She analyzed the opportunities and challenges facing businesses, and provided targeted strategies to help improve the success rate of PMTA applications. She predicted that the FDA is expected to review PMTA applications more efficiently and crack down on unauthorized overseas products entering the market.
CLICK HERE for the {long-version} REPLAY.
It’s critical that the Chinese market continue their innovation and product development, as I have seen some of the most well-loved consumer products come from China - but compliance to our PMTA process is also of upmost importance. Education is the key to drive success on both fronts. Looking forward to our continued partnership with Alan Zhao and Sophia Lv and the 2Firsts team!
Comments